.

Deeper Knowledge, Faster

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Accenture
Federal Trade Commission
Fuji
Dow
US Department of Justice
Chinese Patent Office
Medtronic
Colorcon
US Army
Fish and Richardson

Generated: November 18, 2017

DrugPatentWatch Database Preview

Details for Patent: ► Subscribe

« Back to Dashboard

Details for Patent: ► Subscribe

Title: Glycopeptide disulfide and thioester derivatives
Abstract:Disclosed are disulfide and thioester derivatives of glycopeptides and pharmaceutical compositions containing such glycopeptide derivatives. The disclosed glycopeptide derivatives are useful as antibacterial agents.
Inventor(s): Mu; YongQi (Los Altos, CA)
Assignee: Theravance, Inc. (South San Francisco, CA)
Filing Date:May 01, 2001
Application Number:09/847,048
Claims:1. A glycopeptide of formula II: ##STR10##

wherein: R.sup.3 is --OH; R.sup.5 is hydrogen; R.sup.19 is hydrogen; R.sup.20 is --R.sup.a --S--(CO)--R.sup.h ; R.sup.a is alkylene, alkenylene, alkynylene, cycloalkylene, cycloalkenylene arylene, heteroarylene, heterocyclene, --C(O)-alkylene, --C(O)-alkenylene --C(O)-alkynylene, --C(O)-cycloalkylene, --C(O)-cycloallcenylene --C(O)-arylene, --C(O)-heteroarylene or heterocyclene; and R.sup.h is alkyl, alkenyl, alkynyl, cycloalkyl, cydoalkenyl, aryl, heteroaryl, or heterocyclic; or a pharmaceutically acceptable salt, stereoisonier, or prodrug thereof.

2. The glycopeptide of claim 1, wherein R.sup.a is alkylene, alkenylene, alkynylene, --C(O)-alkylene, --C(O)-alkenylene, or --C(O)-alkynylene, and R.sup.h is alkyl, alkenyl, or alkynyl.

3. A pharmaceutical composition comprising a pharmaceutically acceptable carrier and a therapeutically effective amount of a compound of claim 1.

4. The pharmaceutical composition of claim 3, where the composition further comprises a cyclodextrin.

5. The glycopeptide of claim 1, wherein R.sup.a is alkylene.

6. The glycopeptide of claim 1, wherein R.sup.h is alkyl.

7. A method of treating a mammal having a bacterial disease, the method comprising administering to the mammal a therapeutically effective amount of a glycopeptide of claim 1, thereby effectively treating the bacterial disease.

8. A method of treating a mammal having a bacterial disease, the method comprising administering to the mammal a therapeutically effective amount of a pharmaceutical composition of claim 3, thereby effectively treating the bacterial disease.
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Chubb
Harvard Business School
Cerilliant
Daiichi Sankyo
Farmers Insurance
Covington
Moodys
Accenture
Boehringer Ingelheim
Chinese Patent Office

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot